Future Availability: While currently investigational, it is expected to seek FDA approval in late 2026 or early 2027
It is often prescribed alongside diet and exercise to improve glycemic control
Any reduction in water retention it describes is indirect, following from decreased body weight, lower insulin resistance, and improved metabolic function
1000mg Berberine HCL, 175mcg Chromium, Resveratrol + more Take two capsules daily Supports: GLP-1 production, activates metabolism, helps curb cravings Ideal for treating PCOS, insulin resistance, and metabolic dysfunction Case pack: 6 units Stock this to offer natural GLP-1 support without injections, or as a way to transition off of GLP-1 agonists
Some patients might save significant money by switching from Zepbound to Ozempic if their insurance covers Ozempic
Don't use revenue code 260 (IV Solutions) for subcutaneous or intramuscular injections